Results 41 to 50 of about 2,073 (215)
Patients' preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study [PDF]
, 2018 Background and purpose: The German Institute for Quality and Efficiency in Health Care (IQWiG) previously tested two preference elicitation methods in pilot projects and regarded them as generally feasible for prioritizing outcome-specific results of ...
Seidl, Astrid +9 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
IQWiG-Evidenzbericht zum Thema psychische Folgen eines Schwangerschaftsabbruchs [PDF]
<jats:title>Zusammenfassung</jats:title> <jats:p>Das Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) wurde vom Bundesministerium für Gesundheit beauftragt, bei der Weiterentwicklung der S2k-Leitlinie ...
Tasar, Andrea +2 more
core +1 more source
Economic Evaluation and Transferability of Physical Activity Programmes in Primary Prevention: A Systematic Review [PDF]
, 2010 This systematic review aims to assess the characteristics of, and the clinical and economic evidence provided by, economic evaluations of primary preventive physical exercise interventions, and to analyse their transferability to Germany using ...
Wenig, C.M. +5 more
core +1 more source
Regulatory harmonization: Evolution, globalization and future directions
British Journal of Clinical Pharmacology, EarlyView.Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm +2 more
wiley +1 more source
Systematic Reviews, 2018 Background Previous research shows that many authors of Cochrane overviews were also involved in some of the included systematic reviews (SRs). This type of dual (co-)authorship (DCA) may be a conflict of interest and a potential source of bias.
Dawid Pieper +3 more
doaj +1 more source
Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG
BMC Health Services Research, 2020 Background The question of how to set the cost-effectiveness threshold for new, innovative medicines is a matter of ongoing controversy. One prominent proposal suggests that the cost-effectiveness threshold adopted by the U.K.
Afschin Gandjour
doaj +1 more source
European Policy Analysis, EarlyView.ABSTRACT Policy process research has excelled in explaining structural policy change within national settings, but extensions and applications to the EU level have long proven challenging for scholars. Given that the EU is currently experiencing its longest period of Treaty stability since the 1980s—having evolved into a sui generis political system ...
Vassilis Karokis‐Mavrikos
wiley +1 more source
BMC Medical Research Methodology, 2018 Background Little evidence is available on searches for non-randomized studies (NRS) in bibliographic databases within the framework of systematic reviews.
Elke Hausner +4 more
doaj +1 more source
Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed. [PDF]
, 2010 OBJECTIVES: The methodology for the critical assessment of medical interventions is well established. Regulatory agencies and institutions adhere, in principle, to the same standards. This consistency, however, is not always the case in practice.
Bramlage, P +6 more
core +1 more source